Reasoned therapeutic protocol in outpatients with COVID-19

Area of Science:

• Infectious Diseases
• Virology
• Pharmacology

Background:

• Most SARS-CoV-2 infections (70%) are asymptomatic or mild, not requiring hospitalization.
• A prodromal period of approximately 5 days precedes symptomatic disease in some patients.
• Early management of SARS-CoV-2 in outpatients is crucial to prevent disease progression.

Purpose of the Study:

• To develop evidence-based therapeutic protocols for outpatient management of COVID-19.
• To reduce the impact of SARS-CoV-2 by targeting viral cell entry, inflammation, and prothrombotic effects.
• To tailor treatment strategies based on patient age and comorbidities.

Main Methods:

• Comprehensive literature review on existing COVID-19 therapies.
• Development of structured treatment protocols for outpatients.
• Stratification of treatment recommendations by patient age and comorbidity profile.

Main Results:

• Identification of two distinct therapeutic schemes with proven efficacy.
• Protocols designed to mitigate viral attack, inflammation, and prothrombotic risks.
• Personalized treatment approaches based on individual patient characteristics.

Conclusions:

• The proposed protocols aim to decrease clinical worsening and hospitalization rates.
• Focus on protecting patients in home-based care settings.
• Effective management of SARS-CoV-2 in outpatients can be achieved through tailored therapies.